123 related articles for article (PubMed ID: 8504279)
1. N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate: synthesis and potential utility for the radioiodination of monoclonal antibodies.
Garg PK; Garg S; Zalutsky MR
Nucl Med Biol; 1993 May; 20(4):379-87. PubMed ID: 8504279
[TBL] [Abstract][Full Text] [Related]
2. Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate.
Zalutsky MR; Narula AS
Cancer Res; 1988 Mar; 48(6):1446-50. PubMed ID: 3345515
[TBL] [Abstract][Full Text] [Related]
3. Radioiodination of antibodies via N-succinimidyl 2,4-dimethoxy-3-(trialkylstannyl)benzoates.
Vaidyanathan G; Zalutsky MR
Bioconjug Chem; 1990; 1(6):387-93. PubMed ID: 2099187
[TBL] [Abstract][Full Text] [Related]
4. Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate.
Zalutsky MR; Noska MA; Colapinto EV; Garg PK; Bigner DD
Cancer Res; 1989 Oct; 49(20):5543-9. PubMed ID: 2477144
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunotherapy of breast cancer xenografts with monoclonal antibody ICR12 against c-erbB2 p185: comparison of iodogen and N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate radioiodination methods.
Smellie WJ; Dean CJ; Sacks NP; Zalutsky MR; Garg PK; Carnochan P; Eccles SA
Cancer Res; 1995 Dec; 55(23 Suppl):5842s-5846s. PubMed ID: 7493357
[TBL] [Abstract][Full Text] [Related]
6. A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine.
Zalutsky MR; Narula AS
Int J Rad Appl Instrum A; 1987; 38(12):1051-5. PubMed ID: 2828275
[TBL] [Abstract][Full Text] [Related]
7. Optimization of radioiodination and biotinylation of monoclonal antibody chimeric BR96: an indirect labeling using N-succinimidyl-3-(tri-n-butylstannyl)benzoate conjugate.
Chen J; Strand SE; Sjögren HO
Cancer Biother Radiopharm; 1996 Jun; 11(3):217-26. PubMed ID: 10851540
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of radioiodinated N-succinimidyl iodobenzoate: optimization for use in antibody labelling.
Garg PK; Archer GE; Bigner DD; Zalutsky MR
Int J Rad Appl Instrum A; 1989; 40(6):485-90. PubMed ID: 2551846
[TBL] [Abstract][Full Text] [Related]
9. Maleimidoethyl 3-(tri-n-butylstannyl)hippurate: a useful radioiodination reagent for protein radiopharmaceuticals to enhance target selective radioactivity localization.
Arano Y; Wakisaka K; Ohmomo Y; Uezono T; Mukai T; Motonari H; Shiono H; Sakahara H; Konishi J; Tanaka C
J Med Chem; 1994 Aug; 37(16):2609-18. PubMed ID: 8057303
[TBL] [Abstract][Full Text] [Related]
10. N-succinimidyl 5-(trialkylstannyl)-3-pyridinecarboxylates: a new class of reagents for protein radioiodination.
Garg S; Garg PK; Zalutsky MR
Bioconjug Chem; 1991; 2(1):50-6. PubMed ID: 1878411
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody F(ab')2 fragment labeled with N-succinimidyl 2,4-dimethoxy-3-halobenzoates: in vivo comparison of iodinated and astatinated fragments.
Vaidyanathan G; Affleck D; Zalutsky MR
Nucl Med Biol; 1994 Jan; 21(1):105-10. PubMed ID: 9234271
[TBL] [Abstract][Full Text] [Related]
12. Improved therapeutic efficacy of a monoclonal antibody radioiodinated using N-succinimidyl-3-(tri-n-butylstannyl)benzoate.
Schuster JM; Garg PK; Bigner DD; Zalutsky MR
Cancer Res; 1991 Aug; 51(16):4164-9. PubMed ID: 1714341
[TBL] [Abstract][Full Text] [Related]
13. Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F]fluorobenzoate.
Vaidyanathan G; Zalutsky MR
Int J Rad Appl Instrum B; 1992 Apr; 19(3):275-81. PubMed ID: 1629016
[TBL] [Abstract][Full Text] [Related]
14. Astatine-211 labeling of an antimelanoma antibody and its Fab fragment using N-succinimidyl p-astatobenzoate: comparisons in vivo with the p-[125I]iodobenzoyl conjugate.
Hadley SW; Wilbur DS; Gray MA; Atcher RW
Bioconjug Chem; 1991; 2(3):171-9. PubMed ID: 1932216
[TBL] [Abstract][Full Text] [Related]
15. Preparation of N-succinimidyl 3-[*I]iodobenzoate: an agent for the indirect radioiodination of proteins.
Vaidyanathan G; Zalutsky MR
Nat Protoc; 2006; 1(2):707-13. PubMed ID: 17406300
[TBL] [Abstract][Full Text] [Related]
16. Method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4-iodobenzoate.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Bioconjug Chem; 1997; 8(5):724-9. PubMed ID: 9327137
[TBL] [Abstract][Full Text] [Related]
17. Radioiodination of proteins using N-succinimidyl 4-hydroxy-3-iodobenzoate.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Bioconjug Chem; 1993; 4(1):78-84. PubMed ID: 8431515
[TBL] [Abstract][Full Text] [Related]
18. Catabolism of radioiodinated murine monoclonal antibody F(ab')2 fragment labeled using N-succinimidyl 3-iodobenzoate and Iodogen methods.
Garg PK; Alston KL; Zalutsky MR
Bioconjug Chem; 1995; 6(4):493-501. PubMed ID: 7578370
[TBL] [Abstract][Full Text] [Related]
19. Labeling proteins using aryl iodide acylation agents: influence of meta vs para substitution on in vivo stability.
Garg PK; Slade SK; Harrison CL; Zalutsky MR
Int J Rad Appl Instrum B; 1989; 16(7):669-73. PubMed ID: 2613522
[TBL] [Abstract][Full Text] [Related]
20. Astatination of proteins using an N-succinimidyl tri-n-butylstannyl benzoate intermediate.
Zalutsky MR; Narula AS
Int J Rad Appl Instrum A; 1988; 39(3):227-32. PubMed ID: 2836342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
